TickerFactsScreenerDevelopers

Cardiff Oncology, Inc. (CRDF) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$13.20M2019: -$13.27M2020: -$16.32M2021: -$23.04M2022: -$33.82M2023: -$30.89M2024: -$37.69M2025: -$37.92M-$37.92M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$37.92M-0.6%
2024-$37.69M-22.0%
2023-$30.89M+8.7%
2022-$33.82M-46.8%
2021-$23.04M-41.2%
2020-$16.32M-23.0%
2019-$13.27M-0.5%
2018-$13.20M—